Galvanize Therapeutics Secures $100 Million for Innovative Cancer and Lung Disease Treatments#United_States#Redwood_City#Galvanize_Therapeutics#Sofinnova_Partners#PEF_Technology
Galvanize Therapeutics Secures $100 Million for Innovative Cancer and Lung Disease Treatments
Galvanize Therapeutics has raised $100 million in Series C funding, aiming to revolutionize treatments for cancer and chronic lung disease with its unique PEF technology.
third-news.com
September 3, 2025 at 11:19 AM
Galvanize Therapeutics Secures $100 Million for Innovative Cancer and Lung Disease Treatments#United_States#Redwood_City#Galvanize_Therapeutics#Sofinnova_Partners#PEF_Technology